U.S., April 5 -- ClinicalTrials.gov registry received information related to the study (NCT06910709) titled 'Single and Multiple Ascending Dose Study of AMG 378 in Healthy Participants' on March 28.
Brief Summary: The main objective of the study is to assess the safety and tolerability of AMG 378 as single or multiple doses in healthy participants.
Study Start Date: April 15
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: AMG 378
Oral tablet
DRUG: Placebo
Oral tablet
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Amgen
Disclaimer: Curated by HT Syndication....